“showed a trend”

The impaired patients showed a trend toward significance for more errors than zero in the no distracter condition, t (5) = 2.23, p = 0.076, with three out of six patients making at least one error.

In patients with luminal-A cancers, c-Nectin-4 status was an independent predictor of DFS (HR =.3.5: 95% CI, 1.1–11.6; P =0.038), while it showed a trend toward statistical significance for LRFS (HR=3.9: 95% CI, 0.9–17.6; P =0.076) ( Table 3 ).

As a group, monkeys with ACC lesions showed a trend towards a reduced prosocial preference ( Fig 2A ; baseline Other-Neither = 0.13, postoperative retention Other-Neither = 0.06; t 3 = 3.43, p = 0.076).

However, the NP-B6 conjugate-treated P301S slice culture samples showed a trend towards increased levels of hTAU as compared to the slice cultures receiving other NP treatments ( Figure 5 f, p = 0.076), implicating that some pTAU might have been caught with B6 and pulled into the magnetic fraction by conjugated iron-cored NP using magnetic separation.

Neuropsychological domain scores were broadly comparable, although the MBI group showed a trend toward lower frontal executive composite performance after covariate adjustment ( p = 0.076).

The time spent in the center of the arena ( Figure 3E ) showed a trend for an increase over time [ F (2,259) = 2.609, p = 0.076].

Notably, within this subgroup, patients receiving ≥ 2 cycles of neoadjuvant immunochemotherapy showed a trend towards better overall survival ( P = 0.076) and disease-free survival ( P = 0.062).

CD20 + showed a trend towards better DFS ( p = 0.076).

Participants’ responses showed a trend of being slower when switching entailed greater costs ( t 28 = 1.844, p = 0.076, CI 95 = [−0.003 to 0.056], U3 1 = 0.345).

Among histopathological results, only LVI showed a trend toward statistical significance ( P = .076).

Although not statistically significant, dogs with elevated SDMA showed a trend of being more likely to develop severe neutropenia than those with normal SDMA ( p = 0.076). 3.4.2 GI Toxicity Of the five dogs with elevated SDMA, four (80%) experienced grades 3‐4 GI toxicity.

Additionally, a trend toward better PFS was observed in patients with p53 positivity ≥50% (HR: 0.66 [95% CI: 0.40–1.08], p = 0.097), whereas patients harboring L858R showed a trend toward poor outcome (HR: 1.68 [95% CI: 0.95–2.97], p = 0.076).

Notably, the UB-BJ-02 treatment showed a trend towards increasing the expression of Il-10 (P = 0.076), suggesting a potential anti-inflammatory effect of this treatment.

In contrast, individuals in the increased group had a 2.24-fold higher risk of developing DM compared to the stable group ( P = 0.001), and showed a trend toward increased risks of low cognitive performance ( P = 0.076) and hypertension ( P = 0.071).

Although Group B showed a trend toward fewer missed or false-positive lesions, this did not reach statistical significance (p = 0.076).

Bonferroni post hoc comparisons revealed the main differences between the groups for behavioural disengagement showed a trend towards higher behavioural disengagement in monthly leakers compared to infrequent leakers ( p = 0.076).

Maternal ACEs were not associated with intracranial volume ( r = -0.089, p = .418); and when additionally controlling for sex, postconceptional age at scan and birthweight percentile, intracranial volume showed a trend level association with ACEs ( r = -0.197, p = .076).

Patients with cardiac resynchronization therapy (CRT‐D) showed a trend toward more VAs ( p = 0.076), compared to patients without CRT‐D; no significant difference in mortality was found between patients with and without CRT‐D ( p = 0.63).

After mastectomy, RT showed a trend toward a higher risk of hypothyroidism (HR = 1.248; 95% CI, 0.977–1.595; p = 0.076).

Scanpath probability showed a trend to a negative correlation with their discriminative accuracy (d’) during the experiment [r = −0.42, F (1,17) = 3.55, p = 0.076], as well as a similar trend with their Cambridge Face Memory Test scores [r = −0.44, F (1,17) = 4.02, p = 0.061].

Regarding tumor characteristics, the distribution of CNCL stage showed a trend toward differences (p = 0.076); stage IIa disease was observed in 25.0% of the non-recurrence group compared to 50.0% in the recurrence group, while the distribution of other stages was similar.

Nevertheless, the FCR comparisons showed a trend for statistically significant improvement in C and D groups when compared with the B group ( p = 0.076 and p = 0.01, respectively). 2.2.

Importantly, tumors from responding patients showed a trend toward a more clonal BCR repertoire (FDR-adjusted p = 0.076; Figure S7 ; Table S1 M).

As indicated in Table 3 , most of the statin used showed a trend of a low risk of PH except lovastatin (aHR: 1.63, 95% CI: 0.95–2.79; P = 0.076) Among all of those being used, pravastatin had the lowest aHR and appeared to significantly reduce the risk of PH by 56% (aHR: 0.44, 95% CI: 0.23–0.86; P = 0.016).

Sulfur (S) The ANOVA data showed a trend to lower S levels (F (2.72) = 2.67, p = 0.076, n.s.).